Table II.
Bacteria cultured from used devices of patients with cystic fibrosis
| Bacteria | Total (n = 19) | Devices |
|||
|---|---|---|---|---|---|
| Aerobika (n = 14) | TheraPep (n = 4) | Othera (n = 1) | P-valueb | ||
| No. of devices from which bacteria were cultured | 19 (100%) | 14 (100%) | 4 (100%) | 1 (100%) | |
| Bacillus spp. | 12 (63%) | 10 (71%) | 2 (50%) | NCc | 0.298 |
| Coagulase-negative staphylococci | 8 (42%) | 6 (43%) | 1 (25%) | 1 (100%) | 0.395 |
| Curtobacterium flaccumfaciens | 1 (5%) | 1 (7%) | NC | NC | 0.828 |
| Kocuria rosea | 1 (5%) | 1 (7%) | NC | NC | 0.828 |
| Micrococcus spp. | 9 (47%) | 2 (14%) | 2 (50%) | 1 (100%) | 0.539 |
| Moroxella spp. (not catarrhalis) | 1 (5%) | 1 (7%) | NC | NC | 0.828 |
| Paenibacillus glucanolyticus | 2 (11%) | 2 (7%) | NC | NC | 0.671 |
| Proteus spp. | 1 (5%) | 1 (14%) | NC | NC | 0.828 |
| Pseudomonas koreensis | 1 (5%) | NC | 1 (25%) | NC | 0.138 |
| Stenotrophomonas maltophilia | 5 (26%) | 4 (29%) | 1 (25%) | NC | 0.820 |
NC, not cultured.
a
A device from a wide market selection, excluding Aerobika and TheraPep.
b
χ2-Test comparing abundance of species cultured from various devices.